DN4 PHARMACOECONONOMIC EVALUATION OF SEDATION WITH REMIFENTANIL/PROPOFOLVERSUS MIDAZOLAM/FENTANYL IN THE INTENSIVE CARE UNIT
Nov 1, 2005, 00:00 AM
10.1016/S1098-3015(10)67186-0
https://www.valueinhealthjournal.com/article/S1098-3015(10)67186-0/fulltext
Section Title :
Section Order :
186
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)67186-0&doi=10.1016/S1098-3015(10)67186-0